ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Sanofi-Aventis (Suisse) SA - Efluelda 0.7 ml, suspension injectable en seringue préremplie
6770404
Efluelda 0.7 mlsuspension injectable en seringue préremplie
J07BB02Influenza, Inactivated, Split Virus Or Surface Antigen
16.08.2024  
Composition
haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/4897/2022 (H1N1)-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 60 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Thailand/8/2022 (H3N2)-like: reassortant virus SAN-022 derived from A/California/122/2022) 60 µg, haemagglutininum influenzae B (Virus souche B/Austria/1359417/2021-like: derived from B/Michigan/01/2021 (Victoria lineage)(wild type)) 60 µg, haemagglutininum influenzae B (Virus souche B/Phuket/3073/2013 (Yamagata lineage) (wild type)) 60 µg, natrii chloridum, dinatrii phosphas, natrii dihydrogenophosphas anhydricus, octoxinolum-9, aqua ad iniectabile q.s. ad suspensionem pro 0.7 ml corresp. natrium 2.72 mg.
Packungsbestandteile
  
  
 
Active AgentDose
 60µg / 0.7ml
 60µg / 0.7ml
 60µg / 0.7ml
BAG: Active AgentDose
Influenza-haemagglutinin240 mcg
 
Inactive agentsDose
Disodium Phosphate 
 60µg / 0.7ml
Sodium Chloride 
Sodium Dihydrogenophosphate Anhydrate 
  
 
Package numberPackage SizeEFPCPCategorySLOut of trade (MedRef)
019 PRPRB No
0205PRPRB No
02110PRPRB No
022 31.0048.80BSLNo
0235PRPRB No
02410PRPRB No
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home